RecruitingNot ApplicableNCT07252362

LCMS-Based Metabolic Analysis Explores the Effect of American Ginseng on Urine and Plasma in Healthy Individuals


Sponsor

Zhejiang Cancer Hospital

Enrollment

20 participants

Start Date

Nov 11, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Researchers will use LCMS Metabolic Analysis to Explore the Effect of American Ginseng on Urine and Plasma in Healthy Individuals Participants will: * Take 3 grams of American Ginseng powder every day for 14 days * Collect the fasting urine samples at the following times at the hospital: On the first day, on the 7th day after taking the medicine, and on the 14th day after taking the medicine. * Collect the fasting Serum samples at the following times at the hospital: On the first day and on the 14th day after taking the medicine. * Have their any adverse effects monitored and evaluated throughout the study.


Eligibility

Min Age: 18 YearsMax Age: 45 Years

Inclusion Criteria2

  • to 45 years old;
  • The subjects were fully informed about the research process and signed the informed consent form (the subjects had no abnormalities in routine physical examinations, no previous medical history, and no history of drug allergies); ③ During the trial, they were required to have a light diet and were prohibited from consuming alcoholic and caffeinated beverages;

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAmerican Gginseng

All the subjects took 3 grams of ginseng half an hour after breakfast every day for 14 consecutive days.


Locations(1)

Zhejiang Cancer Hospital

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07252362